Type 1 diabetes mellitus caused by treatment with interferon-β

被引：17

作者：

Kado, S ^{[1
]}

Miyamoto, J ^{[1
]}

Komatsu, N ^{[1
]}

Iwaki, Y ^{[1
]}

Ozaki, H ^{[1
]}

Taguchi, H ^{[1
]}

Kure, M ^{[1
]}

Sarashina, G ^{[1
]}

Watanabe, T ^{[1
]}

Katsura, Y ^{[1
]}

Nemoto, Y ^{[1
]}

Noritake, M ^{[1
]}

Matsuoka, T ^{[1
]}

机构：

[1] Tokyo Med Univ, Dept Internal Med 5, Inashiki, Ibaragi 3000395, Japan

来源：

INTERNAL MEDICINE | 2000年 / 39卷 / 02期

关键词：

GAD antibody; chronic hepatitis; hepatitis C virus; human leukocyte antigen;

D O I：

10.2169/internalmedicine.39.146

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A 57-year-old man was referred to our outpatient clinic after interferon-beta (IFN-beta) treatment for 7 weeks. While IFN-beta therapy was continued in our outpatient clinic, his blood glucose level increased gradually, and he was admitted to our hospital for hyperglycemia. The patient was prescribed a 1,600-kcal diet and intensive insulin therapy was performed. GAD antibody became positive 15 months after the start of IFN therapy, and disappeared 27 months after the start of IFN therapy. Insulin secretion was depleted and the patient had HLA-DR4, B54, and DRB1*0405, This appears to be a case of type 1 diabetes mellitus induced by administration of IFN-beta alone.

引用

页码：146 / 149

页数：4

共 50 条

[21] The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus
Munir, Kashif M.
Davis, Stephen N.
EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (15) : 2331 - 2341
[22] Interferon-α and development of type 1 diabetes -: A case without insulin resistance
Tohda, G
Oida, K
Higashi, S
Hayashi, T
Miyamori, I
DIABETES CARE, 1998, 21 (10) : 1774 - 1774
[23] Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitus
Yagyu, Hiroaki
Okada, Kenta
Sato, Shin
Yamashita, Yumiko
Okada, Nobukazu
Osuga, Jun-ichi
Nagasaka, Shoichiro
Sugano, Kentaro
Ishibashi, Shun
DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 95 (03) : E52 - E54
[24] Interferon-α-2bType 1 diabetes mellitus and autoimmune thyroiditis: case report
Reactions Weekly, 2012, 1409 (1) : 28 - 28
[25] Interferon-αKetoacidosis with shock in a patient with diabetes mellitus: case report
Reactions Weekly, 2000, 827 (1) : 8 - 8
[26] Dapagliflozin for the treatment of type 1 diabetes mellitus
Pafili, Kalliopi
Maltezos, Efstratios
Papanas, Nikolaos
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (07) : 873 - 881
[27] Otelixizumab in the treatment of Type 1 diabetes mellitus
Sprangers, Ben
Van der Schueren, Bart
Gillard, Pieter
Mathieu, Chantal
IMMUNOTHERAPY, 2011, 3 (11) : 1303 - 1316
[28] Thymogen treatment of diabetes mellitus type 1
Zhuk, EA
Galenok, VA
TERAPEVTICHESKII ARKHIV, 1996, 68 (10) : 12 - 14
[29] Treatment of adolescents with type 1 diabetes mellitus
Garg, S
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2004, 17 (05): : 805 - 806
[30] Prevention and treatment of diabetes mellitus type 1
Choukroun, G
PRESSE MEDICALE, 2001, 30 (24): : 21 - 23

← 1 2 3 4 5 →